Clinical Trial Update: Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of the Sancuso patch for chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Sancuso patch (granisetron transdermal system)

Snippet

Sponsor: LG Life Sciences | Conditions: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Phase 4 | Status: COMPLETED